期刊文献+

省部科技会商制度的影响因子分析 被引量:3

An analysis of Influence factors of institutions of consulting in science and technology fields through province and ministry
下载PDF
导出
摘要 省部科技会商制度是新时期的一种创新型制度安排。从会商参与者的时空分布及会商内容分析,会商制度主要受经济实力、科技投入、地缘条件、资源状况、科技基础、产业优势、发展战略、科技计划等8个因子影响。同时,影响因子的耦合作用也影响和制约会商制度的运作。 institutions of consulting in science and technology fields through province and ministry is an innovative institutions arrangements in new era.From Spatial and temporal distribution of participants and the contents of Consultation analysis,there are eight major factors which impact the institutions of consulting,such as economic strength,scientific and technological input,geopolitical conditions,resources conditions,scientific and technological base,industry advantages,development strategy,science and technology plan and so on.At the same time,Coupling of influence factors impact operation of the institutions of consulting too.
作者 何为东
出处 《科学管理研究》 CSSCI 北大核心 2010年第5期31-36,共6页 Scientific Management Research
基金 我国"中央--区域"科技治理研究 2008年教育部科技委战略研究重点项目(教技委〔2008〕14号)
关键词 省部科技会商 影响因子 耦合作用 consulting in science and technology fields through province and ministry influence factors coupling
  • 相关文献

参考文献11

二级参考文献35

  • 1[1]Susanne Giesecke:The contrasting roles of government in the development ofbiotechnology industry in the US and Germany[C],Research Policy 29 2000 205-223.
  • 2[2]Martin Fransman:Biotechnology:Generation,Diffusion and Policy -An Interpretive Survey[R],UNU/INTECH Working Paper No.1.
  • 3[3]Lynne G.Zucker、 Michael R.Darby、Jeff S.Armstrong:COMMERCIALIZING KNOWLEDGE:UNIVERSITY SCIENCE,KNOWLEDGE CAPTURE,AND FIRM PERFORMANCE IN BIOTECHNOLOGY[R],NBER WORKING PAPER 8499.
  • 4[4]Henry Grabowski and John Vermon:The Distribution of Sales from Pharmaceutical Innovation[R],A preliminary version of this paper was presented at a conference in Talloires,France in July 1999 that was hosted by the Tufts University Center for the Study of Drug Development.
  • 5[5]Internal Co-ordination Group for Biotechnology (ICGB):Biotechnology Update[J],No.7,22 June 2000-Responding to the Request of the G8 Heads of State and Government.
  • 6[6]Lawrence M.Rausch:INTER-NATIONAL PATENTING TRENDS IN BIOTECHNOLOGY:GENETIC ENGI-NEERING[R],Division of Science Resources Studies ISSUEBRIEF June 18,1999.
  • 7[7]Jon Paugh and Dr.John C.Lafrance:THE U.S.BIOTECHNOLOGY INDUSTRY[R],U.S.Department of Commerce,Office of Technology Policy.
  • 8[8]Jacqueline Senker、 Orietta Marsili:Literature Review for European Biotechnology Innovation Systems (EBIS)[R],EC TSER Project (SOE1-CT98-1117).
  • 9[9]Jorg C.Mahlich,Thomas Roediger-Schluga:The Changing Nature of Pharmaceutical R&D-Opportunities for Asia[R],MERITInfonomics Reasearch Memorandum series 2001-001.
  • 10[10]G.Steven McMillan,Francis Narin,David L.Deeds:An analysis of the critical role of public science in innovation:the case of biotechnology[R],Research Policy 29 2000 1-8.

共引文献111

同被引文献16

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部